Biocryst Pharmaceuticals reported $461.19M in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
DBV Technologies DBVT:US USD 44.75M 23.46M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Biocryst Pharmaceuticals BCRX:US USD 461.19M 43.71M
Chugai Pharma 4519:JP JPY 274.04B 86.27B
Daiichi Sankyo 4568:JP JPY 480.22B 177.84B
Enanta Pharmaceuticals ENTA:US USD 43.99M 15.63M
Gilead Sciences GILD:US USD 6.94B 2.2B
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Glaxosmithkline GSK:US GBP 3.61B 2.86B
Intra Cellular Therapies ITCI:US USD 135.36M 58.12M
IONIS PHARMACEUT IONS:US USD 314.99M 206.92M
Karyopharm Therapeutics KPTI:US USD 71.35M 10.9M
Mirati Therapeutics MRTX:US USD 173.53M 71.97M
Neurocrine Biosciences NBIX:US USD 212.2M 48.9M
Novavax NVAX:US USD 1.28B 95.01M
Ptc Therapeutics PTCT:US USD 104.42M 53.73M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Roche Holding ROG:VX 4.32B 2.54B
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Ultragenyx Pharmaceutical RARE:US USD 391.65M 231.78M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
YTE INCY:US USD 2.69B 255.24M